TELA Bio, Inc. (TELA)
NASDAQ: TELA · IEX Real-Time Price · USD
4.630
+0.080 (1.76%)
At close: Jul 19, 2024, 4:00 PM
4.690
+0.060 (1.30%)
Pre-market: Jul 22, 2024, 7:26 AM EDT
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $114.15 million as of July 22, 2024. Its market cap has decreased by -53.63% in one year.
Market Cap
114.15M
Enterprise Value
117.41M
1-Year Change
-53.63%
Ranking
Category
Stock Price
$4.63
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $142.10M to $114.15M, a decrease of -19.67%. That is a compound annual growth rate of -4.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 114.20M | -29.55% |
| Dec 29, 2023 | 162.10M | -26.42% |
| Dec 30, 2022 | 220.30M | 18.70% |
| Dec 31, 2021 | 185.60M | -14.51% |
| Dec 31, 2020 | 217.10M | 46.99% |
| Dec 31, 2019 | 147.70M | 3.94% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akoya Biosciences | 116.55M |
| American Well | 116.21M |
| KORU Medical Systems | 115.33M |
| FONAR | 115.17M |
| RAPT Therapeutics | 114.83M |
| aTyr Pharma | 113.18M |
| Telomir Pharmaceuticals | 111.04M |
| Karyopharm Therapeutics | 110.91M |